RCP-Q Comprehensive Real Time PCR Kit

SKU-1: G610005-1
SKU2: G610005-3
SKU3: G610005-5
Product Overview

Respiratory tract infections are among the leading causes of morbidity worldwide and may be caused by a wide range of viral pathogens presenting with highly overlapping clinical symptoms. Patients commonly exhibit fever, cough, sore throat, nasal congestion, breathing difficulty, bronchitis, or pneumonia, making syndromic diagnosis challenging without molecular confirmation. Rapid and accurate identification of respiratory pathogens is critical for timely clinical management, infection control, outbreak monitoring, and appropriate therapeutic decisions.

The RCP-Q Comprehensive Real Time PCR Kit for Respiratory from Genes2Me is a highly multiplexed CE-IVD molecular diagnostic assay designed for the qualitative detection of 4 major parainfluenza serotypes - PIV-1 to PIV- in human clinical samples. The assay utilizes real-time PCR technology across whole workflow, enabling simultaneous detection and differentiation of multiple respiratory viruses associated with upper and lower respiratory tract infections.

Targets:
4 parainfluenza serotypes - PIV-1 to PIV-4
Technology:
Real-Time PCR (Multiplex TaqMan Assay)
Detection:
Qualitative (Detected / Not Detected)
Sample Type:
Sputum, tracheal aspirate, nasopharyngeal aspirate, throat swab, nose swab, and nasopharyngeal swab
Certification:
CE-IVD
RCP-Q Comprehensive

How the Assay Works

The RCP-Q Comprehensive assay is based on multiplex real-time PCR technology. The assay is organized into a multiplex format, where Ready Mix contains optimized primers and probes for a defined pathogen panel along with an Internal/Exogenous Control for process validation and to ensure reliable results. The distinct fluorescent channels enable simultaneous detection of multiple targets in reaction tube. The assay includes dedicated positive controls for each Ready Mix and negative controls for contamination monitoring.

Why Comprehensive Respiratory Molecular Testing Matters

Respiratory infections caused by viral pathogens often present with similar clinical manifestations, making differential diagnosis difficult using symptoms alone. Traditional diagnostic approaches may require multiple sequential tests, increasing turnaround time and delaying treatment decisions.

Comprehensive multiplex molecular testing enables rapid identification of multiple respiratory pathogens in a single workflow, supporting early and accurate diagnosis and appropriate patient isolation and infection control resulting in better management of immunocompromised and high- risk patients.

Sample Type & Reporting Output

Sample Type:
Sputum, tracheal aspirate, nasopharyngeal aspirate, throat swab, nose swab, and nasopharyngeal swab
Reporting Output:
Qualitative detection of respiratory pathogens (Detected / Not Detected)
Targets Detected:
4 parainfluenza serotypes - PIV-1 to PIV-4

Key Features & Benefits

Optimized multiplex assay design

Efficient multiplex configuration minimizes time and reagent consumption while maintaining high analytical performance and target specificity.

Broad respiratory pathogen coverage

Covers 4 major parainfluenza serotypes - Parainfluenza Virus1, Parainfluenza Virus 2, Parainfluenza Virus 3, and Parainfluenza Virus 4

Built-in internal and exogenous controls

Integrated controls validate nucleic acid extraction, amplification efficiency, and sample integrity while helping identify PCR inhibition.

Compatible with leading PCR platforms

Validated on RapiCycler 96, Bio-Rad CFX96 Touch, QuantStudio 5, and LightCycler 480 systems for seamless laboratory integration.

Applications

  • Clinical & Hospital Laboratories: Supports rapid and comprehensive diagnosis of respiratory tract infections in symptomatic patients presenting with fever, cough, respiratory distress, or pneumonia.
  • Respiratory Infection Panels: Ideal for syndromic respiratory testing where multiple viral pathogens may present with similar clinical symptoms.
  • Outbreak Surveillance & Public Health: Enables rapid identification and monitoring of circulating respiratory pathogens during seasonal outbreaks and epidemic events.

Analytical Performance

  • Multiplex qualitative detection of 28 respiratory pathogens across all optimized reaction mixes
  • Ct cut-off value of ≤35 for positive detection
  • Analytical sensitivity and specificity of 100%
  • Limit of detection as low as 100 copies/ml for highly sensitive molecular analysis
  • Excellent linearity with R² 0.999 across the quantification range
  • Clinical sensitivity of 99% and clinical specificity of 98%

Data Analysis and Report

RCP-Q Comprehensive

RCP-Q Comprehensive PCR specific amplification plot of Treponema pallidum Positive Control (HEX Channel) along with Internal Control (Cy5 Channel)

Ordering Information

Commercial Name Old Cat No. New Cat No. Pack Size
RCP-Q Comprehensive Real Time PCR Kit G2M803521 G610005 50 Tests

Product Enquiry Form

Other Products

Rapi-Q Series
Rapi-Q

Rapid and Compact Point-of-care RT-PCR Testing Solution.

Rapi-X96
RAPiCycler-96

Real time PCR system to process 96 samples.
TRapi-X96
Rapi-X16

Compact Nucleic Acid Extraction System Ideal for Point-of-Care Testing

Since its inception in 2016, Genes2me has been constantly striving towards setting a benchmark in the diagnostics space by introducing premium quality (Made in India) diagnostic kits which are CE-IVD, ISO-13485:2016, and ISO 9001:2015 certified, assuring our clients of unparalleled quality and compliance with international standards.

© 2025 Genes2me. All rights reserved.